Social Anxiety DisorderNCT05292612
CvC-SAD (Clinician vs Coach)Self-help Versions in a RCT
A study testing iCBT(C&W) for SAD in people with Social Anxiety Disorder, run by Chinese University of Hong Kong at 1 site in Hong Kong.
Trial summary
Background: Social Anxiety Disorder (SAD) is a common mental problem, where people experience severe and disabling anxiety about social situations and interactions. It is highly prevalent world-wide and in Hong Kong, causing significant suffering/distress. Read more about this study
- Who is it for?
- Ages 18 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Social Anxiety Disorder
- What is being tested?
- iCBT(C&W) for SAD
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 110 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 May 2023to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Meets DSM-5 criteria for SAD (SAD must be generalised, not the 'performance only' subtype)
- Considers SAD their main problem
- Age 18 or over (no upper age limit)
- No current psychotropic mediation, or on a stable dose for at least two months without improvement, and willing to remain at this dose throughout trial
- Participant agrees not to start any other forms of treatment during the trial
- Chinese resident of Hong Kong
- Proficient in written traditional Chinese and spoken Cantonese
- Internet access from home
Who cannot join
- current or past psychosis, bipolar disorder, or borderline personality disorder
- active suicidality
- 'Moderate' or 'Severe' Alcohol Use Disorder or Substance Use Disorder (based on DSM-5)
- No current or previous CBT for SAD (defined as at least 5 sessions, and including an exposure component), including internet-CBT studies
- Not another current emotional problem that is the participant's main concern (Participant must not be largely absorbed in another emotional problem, for which it would be unethical not to address as a priority)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
The Chinese University of Hong Kong
Shatin
PATRICK LEUNG, 3943 6502, pleung@cuhk.edu.hk
About this study
Official title: Chinese Internet-delivered Cognitive Therapy for Social Anxiety Disorder in Hong Kong: A Randomised Controlled Noninferiority Trial to Compare Clinician Versus Coach Guidance
Background:
Social Anxiety Disorder (SAD) is a common mental problem, where people experience severe and disabling anxiety about social situations and interactions. It is highly prevalent world-wide and in Hong Kong, causing significant suffering/distress. While evidence-based interventions exist, e.g., cognitive behavioural therapy (CBT), there will be not enough trained therapists to meet the treatment demand so that the majority of the SAD patients receive no treatment. Internet-based therapies may offer a solution, given that they deliver treatment more cost-efficiently by requiring lesser therapist time so that more patients can be treated with the same therapist resources. One UK internet-based CBT protocol for SAD, iCBT(C\&W), shows high efficacy and efficiency in initial UK and Hong Kong trials with Englishspeaking patients.
Read more
Objectives:
- To develop and confirm the efficacy of a Chinese-language version of iCBT(C\&W), administered by clinical psychologists in standard therapist-guided format.
- To develop an even more cost-efficient new self-help format with some minimal 'coaching' performed by trained psychology bachelor-level graduates - its efficacy expected as 'noninferior' to that of the therapist-guided format.
Overall design:
Three-arm parallel group randomised controlled noninferiority trial: Standard therapist-guided iCT-SAD vs. Guided self-help iCT-SAD vs. Waitlist
Method:
The iCBT(C\&W) protocol will be translated into Chinese. Approximately 110 Chinese adults with SAD will be recruited in Hong Kong and randomised into one of two treatment conditions, therapist-guided versus self-help. The treatment lasts 14 weeks. The primary outcome measure will be Liebowitz Social Anxiety Scale (self-report version).
- Conditions
- Social Anxiety Disorder
- Being tested
- iCBT(C&W) for SAD
- Medical subject headings
- Phobia, Social
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
iCBT(C&W) for SADBehavioural
iCBT(C\&W) for SAD implements all the key procedures of the face-to-face treatment. Patients are guided through the treatment by using secure messaging and regular telephone or webcam calls. The treatment comprises a series of online modules, each of which includes educational texts, patient testimonies, video illustrations, case examples, questionand- answer boxes, monitoring sheets, behavioural experiments and other homework assignments.
| Study group | Role | What they receive |
|---|---|---|
| Standard therapist-guided iCT-SAD vs. Waitlist | Experimental | to examine if standard iCT-SAD delivered in Chinese is superior to waitlist.
participants in the experimental group would receive iCBT(C\&W) for SAD under the guidance of trained therapist. Receives: Behavioral: iCBT(C&W) for SAD |
| Guided self-help iCT-SAD vs. Waitlist | Experimental | to examine if guided self-help iCT-SAD delivered in Chinese is superior to waitlist.
participants in the experimental group would receive iCBT(C\&W) for SAD under the guidance of trained coaches. Receives: Behavioral: iCBT(C&W) for SAD |
| Standard therapist-guided iCT-SAD vs. Guided self-help iCT-SAD | Experimental | to examine if guided self-help iCT-SAD is noninferior to standard iCT-SAD.
participants would be randomised into two groups. one group of participants would receive iCBT(C\&W) for SAD under the guidance of trained therapist while the other group of participants would receive iCBT(C\&W) for SAD under the guidance of trained coaches. Receives: Behavioral: iCBT(C&W) for SAD |
What is being measured
The primary outcome is the main question the study is designed to answer.
Liebowitz Social Anxiety Scale, Self-report version (LSAS)
LSAS consists of twenty-four items to assess individual's fear and avoidance towards different social interactions and performance situations. A total of six subscale scores could be obtained in LSAS, including the total fear, fear of social interactions, fear of performance situations, total avoidance, avoidance of social interactions, and avoidance of performance situations.
Measured: through study completion, an average of 14 weeks
Liebowitz Social Anxiety Scale, Self-report version (LSAS)
LSAS consists of twenty-four items to assess individual's fear and avoidance towards different social interactions and performance situations. A total of six subscale scores could be obtained in LSAS, including the total fear, fear of social interactions, fear of performance situations, total avoidance, avoidance of social interactions, and avoidance of performance situations.
Measured: at 3-month post-treatment follow-up
Liebowitz Social Anxiety Scale, Self-report version (LSAS)
LSAS consists of twenty-four items to assess individual's fear and avoidance towards different social interactions and performance situations. A total of six subscale scores could be obtained in LSAS, including the total fear, fear of social interactions, fear of performance situations, total avoidance, avoidance of social interactions, and avoidance of performance situations.
Measured: at 9-month post-treatment follow-up
Secondary outcomes (22)
Patient Health Questionnaire-Depression Scale (PHQ-9)
PHQ-9 consists of nine items that captures the criterion symptoms of DSM-5 major depressive disorder
Measured: through study completion, an average of 14 weeks
Patient Health Questionnaire-Depression Scale (PHQ-9)
PHQ-9 consists of nine items that captures the criterion symptoms of DSM-5 major depressive disorder
Measured: at 3-month post-treatment follow-up
Patient Health Questionnaire-Depression Scale (PHQ-9)
PHQ-9 consists of nine items that captures the criterion symptoms of DSM-5 major depressive disorder
Measured: at 9-month post-treatment follow-up
Generalized Anxiety Disorder-7 (GAD-7)
GAD-7 consists of seven items that captures the criterion symptoms of DSM-5 common anxiety disorders
Measured: through study completion, an average of 14 weeks
Generalized Anxiety Disorder-7 (GAD-7)
GAD-7 consists of seven items that captures the criterion symptoms of DSM-5 common anxiety disorders
Measured: at 3-month post-treatment follow-up
Generalized Anxiety Disorder-7 (GAD-7)
GAD-7 consists of seven items that captures the criterion symptoms of DSM-5 common anxiety disorders
Measured: at 9-month post-treatment follow-up
Work and Social Adjustment Scale (WSAS)
WSAS consists of five items that measure participants' perceived functional impairment incurred by their presenting psychiatric problem (which, in this study, refers to SAD)
Measured: through study completion, an average of 14 weeks
Work and Social Adjustment Scale (WSAS)
WSAS consists of five items that measure participants' perceived functional impairment incurred by their presenting psychiatric problem (which, in this study, refers to SAD)
Measured: at 3-month post-treatment follow-up
Work and Social Adjustment Scale (WSAS)
WSAS consists of five items that measure participants' perceived functional impairment incurred by their presenting psychiatric problem (which, in this study, refers to SAD)
Measured: at 9-month post-treatment follow-up
Social Phobia Weekly Summary Scale (SPWSS)
SPWSS is a five-item self-report questionnaire on social anxiety, social avoidance, self-focused versus external-focused attention, anticipatory processing, and post-event rumination.
Measured: through study completion, an average of 14 weeks
Social Phobia Weekly Summary Scale (SPWSS)
SPWSS is a five-item self-report questionnaire on social anxiety, social avoidance, self-focused versus external-focused attention, anticipatory processing, and post-event rumination.
Measured: at 3-month post-treatment follow-up
Social Phobia Weekly Summary Scale (SPWSS)
SPWSS is a five-item self-report questionnaire on social anxiety, social avoidance, self-focused versus external-focused attention, anticipatory processing, and post-event rumination.
Measured: at 9-month post-treatment follow-up
Behavioural social performance
A behavioural assessment scheme, which includes the Simulated Social Interaction Test, unstructured conversation tasks and an impromptu speech, is adopted to measure social performance. Self-ratings of the behavioural scheme in skill and anxiety domains will be obtained by participants (self ratings) and observers (observer ratings). Ratings will be given in a 5-point Likert Scale. In the anxiety domain, 1 refers to the least anxiety while 5 refers to the most anxiety. In the skill domain, 1 refers to the worst skill and 5 refers to the best skill. Mean scores of the ratings will be calculated and used for analysis.
Measured: at baseline
Behavioural social performance
A behavioural assessment scheme, which includes the Simulated Social Interaction Test, unstructured conversation tasks and an impromptu speech, is adopted to measure social performance. Self-ratings of the behavioural scheme in skill and anxiety domains will be obtained by participants (self ratings) and observers (observer ratings). Ratings will be given in a 5-point Likert Scale. In the anxiety domain, 1 refers to the least anxiety while 5 refers to the most anxiety. In the skill domain, 1 refers to the worst skill and 5 refers to the best skill. Mean scores of the ratings will be calculated and used for analysis.
Measured: 1 week after completing the 14-week treatment
Social Participation (SP)
Social Participation (SP) is a self-report questionnaire for evaluation of one's frequency of social participation from different social relationships. It is measured in a 7-point Likert Scale on the frequency of participation in 13 different social contexts where "1" refers to "never participated" and "7" refers to "always participated". The higher the score, the better the social functioning outcome.
Measured: At baseline
Social Participation (SP)
Social Participation (SP) is a self-report questionnaire for evaluation of one's frequency of social participation from different social relationships. It is measured in a 7-point Likert Scale on the frequency of participation in 13 different social contexts where "1" refers to "never participated" and "7" refers to "always participated". The higher the score, the better the social functioning outcome.
Measured: week 8 of treatment
Social Participation (SP)
Social Participation (SP) is a self-report questionnaire for evaluation of one's frequency of social participation from different social relationships. It is measured in a 7-point Likert Scale on the frequency of participation in 13 different social contexts where "1" refers to "never participated" and "7" refers to "always participated". The higher the score, the better the social functioning outcome.
Measured: 1 week after completing the 14-week treatment
Social Participation (SP)
Social Participation (SP) is a self-report questionnaire for evaluation of one's frequency of social participation from different social relationships. It is measured in a 7-point Likert Scale on the frequency of participation in 13 different social contexts where "1" refers to "never participated" and "7" refers to "always participated". The higher the score, the better the social functioning outcome.
Measured: 3-month post-treatment follow-up
Social Satisfaction (SS)
Social Participation (SP) is a self-report questionnaire for evaluation of one's subjective satisfaction from 5 different social relationships where "1" refers to "the least satisfaction" and "7" refers to "the most satisfaction". The higher the score, the better the social functioning outcome.
Measured: At baseline
Social Satisfaction (SS)
Social Participation (SP) is a self-report questionnaire for evaluation of one's subjective satisfaction from 5 different social relationships where "1" refers to "the least satisfaction" and "7" refers to "the most satisfaction". The higher the score, the better the social functioning outcome.
Measured: week 8 of treatment
Social Satisfaction (SS)
Social Participation (SP) is a self-report questionnaire for evaluation of one's subjective satisfaction from 5 different social relationships where "1" refers to "the least satisfaction" and "7" refers to "the most satisfaction". The higher the score, the better the social functioning outcome.
Measured: 1 week after completing the 14-week treatment
Social Satisfaction (SS)
Social Participation (SP) is a self-report questionnaire for evaluation of one's subjective satisfaction from 5 different social relationships where "1" refers to "the least satisfaction" and "7" refers to "the most satisfaction". The higher the score, the better the social functioning outcome.
Measured: 3-month post-treatment follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Mar 2022
- Study start1 May 2023
- Primary completion30 Sep 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Social Anxiety DisorderStudies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 110 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Prof. Patrick Wing-Leung LEUNG, Chinese University of Hong Kong
- Investigators
- Patrick Leung, Prof., Principal investigator, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05292612
- Sponsor's protocol ID
- 2022.086-T
- Status last verified
- Feb 2026
- First submitted
- 23 Feb 2022
- Last updated
- 18 Feb 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Chinese Internet-delivered Cognitive Therapy for Social Anxiety Disorder in Hong Kong: A Randomised Controlled Noninferiority Trial to Compare Clinician Versus Coach Guidance
- ClinicalTrials.gov ID
- NCT05292612
- Acronym / sponsor ID
- 2022.086-T
- Conditions
- Social Anxiety Disorder
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 110 participants (estimated)
- Lead sponsor
- Chinese University of Hong KongUniversity, hospital or other
- Study start
- 1 May 2023 (actual)
- Primary completion
- 30 Sep 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 23 Mar 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background:
Social Anxiety Disorder (SAD) is a common mental problem, where people experience severe and disabling anxiety about social situations and interactions. It is highly prevalent world-wide and in Hong Kong, causing significant suffering/distress. While evidence-based interventions exist, e.g., cognitive behavioural therapy (CBT), there will be not enough trained therapists to meet the treatment demand so that the majority of the SAD patients receive no treatment. Internet-based therapies may offer a solution, given that they deliver treatment more cost-efficiently by requiring lesser therapist time so that more patients can be treated with the same therapist resources. One UK internet-based CBT protocol for SAD, iCBT(C\&W), shows high efficacy and efficiency in initial UK and Hong Kong trials with Englishspeaking patients.
Objectives:
- To develop and confirm the efficacy of a Chinese-language version of iCBT(C\&W), administered by clinical psychologists in standard therapist-guided format.
- To develop an even more cost-efficient new self-help format with some minimal 'coaching' performed by trained psychology bachelor-level graduates - its efficacy expected as 'noninferior' to that of the therapist-guided format.
Overall design:
Three-arm parallel group randomised controlled noninferiority trial: Standard therapist-guided iCT-SAD vs. Guided self-help iCT-SAD vs. Waitlist
Method:
The iCBT(C\&W) protocol will be translated into Chinese. Approximately 110 Chinese adults with SAD will be recruited in Hong Kong and randomised into one of two treatment conditions, therapist-guided versus self-help. The treatment lasts 14 weeks. The primary outcome measure will be Liebowitz Social Anxiety Scale (self-report version).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Standard therapist-guided iCT-SAD vs. Waitlist | Experimental | Behavioral: iCBT(C&W) for SADto examine if standard iCT-SAD delivered in Chinese is superior to waitlist. participants in the experimental group would receive iCBT(C\&W) for SAD under the guidance of trained therapist. |
| Guided self-help iCT-SAD vs. Waitlist | Experimental | Behavioral: iCBT(C&W) for SADto examine if guided self-help iCT-SAD delivered in Chinese is superior to waitlist. participants in the experimental group would receive iCBT(C\&W) for SAD under the guidance of trained coaches. |
| Standard therapist-guided iCT-SAD vs. Guided self-help iCT-SAD | Experimental | Behavioral: iCBT(C&W) for SADto examine if guided self-help iCT-SAD is noninferior to standard iCT-SAD. participants would be randomised into two groups. one group of participants would receive iCBT(C\&W) for SAD under the guidance of trained therapist while the other group of participants would receive iCBT(C\&W) for SAD under the guidance of trained coaches. |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Meets DSM-5 criteria for SAD (SAD must be generalised, not the 'performance only' subtype)
- Considers SAD their main problem
- Age 18 or over (no upper age limit)
- No current psychotropic mediation, or on a stable dose for at least two months without improvement, and willing to remain at this dose throughout trial
- Participant agrees not to start any other forms of treatment during the trial
Key exclusion criteria (5 listed)
- current or past psychosis, bipolar disorder, or borderline personality disorder
- active suicidality
- 'Moderate' or 'Severe' Alcohol Use Disorder or Substance Use Disorder (based on DSM-5)
- No current or previous CBT for SAD (defined as at least 5 sessions, and including an exposure component), including internet-CBT studies
- Not another current emotional problem that is the participant's main concern (Participant must not be largely absorbed in another emotional problem, for which it would be unethical not to address as a priority)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| iCBT(C&W) for SADiCBT(C\&W) for SAD implements all the key procedures of the face-to-face treatment. Patients are guided through the treatment by using secure messaging and regular telephone or webcam calls. The treatment comprises a series of online modules, each of which includes educational texts, patient testimonies, video illustrations, case examples, questionand- answer boxes, monitoring sheets, behavioural experiments and other homework assignments. | Behavioural | Guided self-help iCT-SAD vs. Waitlist, Standard therapist-guided iCT-SAD vs. Guided self-help iCT-SAD, Standard therapist-guided iCT-SAD vs. Waitlist |
Primary outcome
Liebowitz Social Anxiety Scale, Self-report version (LSAS)
Time frame: through study completion, an average of 14 weeks
LSAS consists of twenty-four items to assess individual's fear and avoidance towards different social interactions and performance situations. A total of six subscale scores could be obtained in LSAS, including the total fear, fear of social interactions, fear of performance situations, total avoidance, avoidance of social interactions, and avoidance of performance situations.
Liebowitz Social Anxiety Scale, Self-report version (LSAS)
Time frame: at 3-month post-treatment follow-up
LSAS consists of twenty-four items to assess individual's fear and avoidance towards different social interactions and performance situations. A total of six subscale scores could be obtained in LSAS, including the total fear, fear of social interactions, fear of performance situations, total avoidance, avoidance of social interactions, and avoidance of performance situations.
Liebowitz Social Anxiety Scale, Self-report version (LSAS)
Time frame: at 9-month post-treatment follow-up
LSAS consists of twenty-four items to assess individual's fear and avoidance towards different social interactions and performance situations. A total of six subscale scores could be obtained in LSAS, including the total fear, fear of social interactions, fear of performance situations, total avoidance, avoidance of social interactions, and avoidance of performance situations.
22 secondary outcomes
Patient Health Questionnaire-Depression Scale (PHQ-9)
Time frame: through study completion, an average of 14 weeks
Patient Health Questionnaire-Depression Scale (PHQ-9)
Time frame: at 3-month post-treatment follow-up
Patient Health Questionnaire-Depression Scale (PHQ-9)
Time frame: at 9-month post-treatment follow-up
Generalized Anxiety Disorder-7 (GAD-7)
Time frame: through study completion, an average of 14 weeks
Generalized Anxiety Disorder-7 (GAD-7)
Time frame: at 3-month post-treatment follow-up
Generalized Anxiety Disorder-7 (GAD-7)
Time frame: at 9-month post-treatment follow-up
Work and Social Adjustment Scale (WSAS)
Time frame: through study completion, an average of 14 weeks
Work and Social Adjustment Scale (WSAS)
Time frame: at 3-month post-treatment follow-up
Work and Social Adjustment Scale (WSAS)
Time frame: at 9-month post-treatment follow-up
Social Phobia Weekly Summary Scale (SPWSS)
Time frame: through study completion, an average of 14 weeks
Social Phobia Weekly Summary Scale (SPWSS)
Time frame: at 3-month post-treatment follow-up
Social Phobia Weekly Summary Scale (SPWSS)
Time frame: at 9-month post-treatment follow-up
Behavioural social performance
Time frame: at baseline
Behavioural social performance
Time frame: 1 week after completing the 14-week treatment
Social Participation (SP)
Time frame: At baseline
Social Participation (SP)
Time frame: week 8 of treatment
Social Participation (SP)
Time frame: 1 week after completing the 14-week treatment
Social Participation (SP)
Time frame: 3-month post-treatment follow-up
Social Satisfaction (SS)
Time frame: At baseline
Social Satisfaction (SS)
Time frame: week 8 of treatment
Social Satisfaction (SS)
Time frame: 1 week after completing the 14-week treatment
Social Satisfaction (SS)
Time frame: 3-month post-treatment follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Social Anxiety Disorder
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Bonding Before Birth: A mHealth Intervention for First-time Expectant Couples
Anxiety, Pregnancy
Recruiting
Comprehensive Assessment of Rehabilitation Experience Using the SAFE Scale
Caregiver Anxiety, Acquired Brain Injury
Not yet recruiting
Online Study on the Impact of a Self-Help Tool for Social Anxiety
Social Anxiety
Active, not recruiting
Targeting Social Function in Anxiety and Eating Disorders
Eating Disorders, Anorexia Nervosa
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Patrick Leung, Prof. principal investigator
Chinese University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing iCBT(C&W) for SAD in people with Social Anxiety Disorder, run by Chinese University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Patrick Leung, Prof. (+85239436502, pleung@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Liebowitz Social Anxiety Scale, Self-report version (LSAS) (time frame: through study completion, an average of 14 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.